Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shuangqing granules for non-alcoholic simple fatty liver disease
CTR20130902Phase 3Active
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of shuangqing granules in metabolic dysfunction-associated steatotic liver disease (MASLD). Started Oct 2013; status: active.
02
Drugs
shuangqing granules
03
Conditions
metabolic dysfunction-associated steatotic liver disease (MASLD)
Beyond the preview
Go deeper on CTR20130902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130902.